Mammoth Biosciences
“Mammoth is honored to welcome California Innovation Fund as an investor and supporter who, together with our existing and new investors, will enable us to accelerate the discovery and development of in vivo gene editing therapeutics and bring more potential ground-breaking medicines to patients.”
- Trevor Martin, Co-founder and CEO
Mammoth is an iconic UC Berkeley startup trying to transform patient lives by developing in vivo gene editing therapeutics. Founded by CRISPR pioneer and recent Nobel Prize Winner Professor Jennifer Doudna, along with founders Trevor Martin, Janice Chen, and Lucas Harrington, Mammoth applies CRISPR techniques to build out its wholly owned pipeline of revolutionary therapeutics.
